J Virol. 2007 Apr;81(8):4381-5. Epub 2007 Feb 7.

Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitors.

Daelemans D, Lu R, De Clercq E, Engelman A.

Source

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. dirk.daelemans@rega.kuleuven.be

Abstract

Integrase is actively studied as an antiviral target, but many inhibitors selected from biochemical screens fail to inhibit human immunodeficiency virus (HIV) replication or primarily affect off-site targets. Here we develop and validate a replication-competent, simian virus 40-HIV integrase mutant chimera as a novel tool to classify the mechanism of action of potential integrase inhibitors. Whereas the mutant was more susceptible than the wild type to entry, reverse transcriptase, and protease inhibitors, it specifically resisted the action of integrase inhibitor L-870,810. We furthermore demonstrate inhibition of integration by GS-9137 and GS-9160 and off-site targeting by the 6-aminoquinolone antibiotic WM-5.

PMID:: 17287285; [PubMed - indexed for MEDLINE]
PMCID:: PMC1866133

Free PMC Article

Images from this publication.See all images (3) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

HIV Integrase Inhibitors

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral. [Antimicrob Agents Chemother. 2...]
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Garvey EP, Johns BA, Gartland MJ, Foster SA, Miller WH, Ferris RG, Hazen RJ, Underwood MR, Boros EE, Thompson JB, et al. Antimicrob Agents Chemother. 2008 Mar; 52(3):901-8. Epub 2007 Dec 26.
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors. [Antimicrob Agents Chemother. 2...]
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors.
Hombrouck A, Van Remoortel B, Michiels M, Noppe W, Christ F, Eneroth A, Sahlberg BL, Benkestock K, Vrang L, Johansson NG, et al. Antimicrob Agents Chemother. 2008 Aug; 52(8):2861-9. Epub 2008 Jun 9.
Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. [Antimicrob Agents Chemother. 2...]
Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase.
Vandegraaff N, Kumar R, Hocking H, Burke TR Jr, Mills J, Rhodes D, Burrell CJ, Li P. Antimicrob Agents Chemother. 2001 Sep; 45(9):2510-6.
Review HIV-1 integration as a target for antiretroviral therapy: a review. [Curr Drug Targets Infect Disor...]
Review HIV-1 integration as a target for antiretroviral therapy: a review.
Pluymers W, De Clercq E, Debyser Z. Curr Drug Targets Infect Disord. 2001 Aug; 1(2):133-49.
Review Novel inhibitors of HIV-1 integration. [Curr Drug Metab. 2004]
Review Novel inhibitors of HIV-1 integration.
Witvrouw M, Van Maele B, Vercammen J, Hantson A, Engelborghs Y, De Clercq E, Pannecouque C, Debyser Z. Curr Drug Metab. 2004 Aug; 5(4):291-304.

See reviews... See all...

Cited by 3 PubMed Central articles

Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activity. [Antimicrob Agents Chemother. 2...]
Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activity.
Koh Y, Haim H, Engelman A. Antimicrob Agents Chemother. 2011 Jan; 55(1):42-9. Epub 2010 Nov 8.
Review HIV-1 IN inhibitors: 2010 update and perspectives. [Curr Top Med Chem. 2009]
Review HIV-1 IN inhibitors: 2010 update and perspectives.
Marchand C, Maddali K, Métifiot M, Pommier Y. Curr Top Med Chem. 2009; 9(11):1016-37.
Review Molecular targets for flavivirus drug discovery. [Antiviral Res. 2009]
Review Molecular targets for flavivirus drug discovery.
Sampath A, Padmanabhan R. Antiviral Res. 2009 Jan; 81(1):6-15. Epub 2008 Sep 15.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Characterization of a replication-competent, integrase-defective human immunodef...
Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitors.
J Virol. 2007 Apr ;81(8):4381-5. Epub 2007 Feb 7 .

PubMed
Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation d...
Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
J Virol. 2007 Apr ;81(8):3949-68. Epub 2007 Feb 7 .

PubMed
An affinity-enhanced neutralizing antibody against the membrane-proximal externa...
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
J Virol. 2007 Apr ;81(8):4033-43. Epub 2007 Feb 7 .

PubMed
Restraint and self-injury in people with intellectual disabilities: a review.
Restraint and self-injury in people with intellectual disabilities: a review.
J Intellect Disabil. 2007 Mar ;11(1):105-18.

PubMed
Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonar...
Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease.
J Thorac Cardiovasc Surg. 1992 Jan ;103(1):87-97.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: